Stericycle, Inc. (NASDAQ:SRCL) – Analysts at William Blair lowered their FY2017 earnings per share (EPS) estimates for shares of Stericycle in a note issued to investors on Wednesday. William Blair analyst R. Daniels now anticipates that the business services provider will earn $4.46 per share for the year, down from their previous estimate of $4.60. William Blair has a “Ourperform” rating on the stock. William Blair also issued estimates for Stericycle’s Q4 2017 earnings at $1.12 EPS, Q1 2018 earnings at $1.13 EPS, Q2 2018 earnings at $1.18 EPS, Q3 2018 earnings at $1.11 EPS and FY2018 earnings at $4.46 EPS.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.92%. The business had revenue of $883.00 million during the quarter, compared to analysts’ expectations of $896.81 million. During the same period last year, the business posted $1.24 earnings per share. The company’s revenue for the quarter was down .8% compared to the same quarter last year. ILLEGAL ACTIVITY NOTICE: “Stericycle, Inc. Forecasted to Earn FY2017 Earnings of $4.46 Per Share (SRCL)” was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.watchlistnews.com/stericycle-inc-forecasted-to-earn-fy2017-earnings-of-4-46-per-share-srcl/1694606.html.

Several other research firms have also commented on SRCL. Zacks Investment Research lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. BMO Capital Markets dropped their price objective on shares of Stericycle from $74.00 to $62.00 and set a “market perform” rating for the company in a research note on Friday. BidaskClub lowered shares of Stericycle from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Barclays PLC reaffirmed an “overweight” rating and set a $100.00 price objective on shares of Stericycle in a research note on Wednesday, August 9th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $85.00 price objective (down from $95.00) on shares of Stericycle in a research note on Thursday. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $77.17.

Stericycle (SRCL) opened at $64.02 on Friday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.87 and a current ratio of 0.87. The company has a market cap of $5,470.00, a price-to-earnings ratio of 15.46, a price-to-earnings-growth ratio of 1.80 and a beta of 0.19. Stericycle has a one year low of $61.62 and a one year high of $88.00.

Several large investors have recently added to or reduced their stakes in SRCL. Schroder Investment Management Group bought a new stake in shares of Stericycle during the second quarter worth $80,497,000. Thompson Siegel & Walmsley LLC bought a new stake in shares of Stericycle during the second quarter worth $33,710,000. Strs Ohio lifted its position in shares of Stericycle by 26,943.3% during the second quarter. Strs Ohio now owns 328,306 shares of the business services provider’s stock worth $25,056,000 after purchasing an additional 327,092 shares during the last quarter. BlackRock Inc. lifted its position in shares of Stericycle by 6.4% during the second quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock worth $413,139,000 after purchasing an additional 323,664 shares during the last quarter. Finally, Clarkston Capital Partners LLC lifted its position in shares of Stericycle by 43.1% during the third quarter. Clarkston Capital Partners LLC now owns 1,013,885 shares of the business services provider’s stock worth $72,614,000 after purchasing an additional 305,441 shares during the last quarter. Institutional investors and hedge funds own 94.13% of the company’s stock.

In other news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction on Monday, October 30th. The stock was sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the completion of the sale, the director now directly owns 205,576 shares in the company, valued at $14,497,219.52. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 3.30% of the stock is currently owned by company insiders.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.